Research

Don’t be a Statistic. Medical Mistakes are the Third Leading Cause of Death in the United States.

A recent Johns Hopkins study found medical mistakes are the third leading cause of death in the United States, killing between 200,000 and 400,000 per year. The study does not even consider misdiagnoses, or how many people suffer injuries without dying. We frequently see people who are medicated for what doctors think are diseases, but are actually symptoms with underlying ...

Read More »

New Study Finds Link between Celiac Disease and Obesity in Patients

[Editor’s Note: Originally published October, 11, 2012] Lately, it seems like more and more celebrities and professional athletes are openly talking about going gluten free. Whether it’s due to a diagnosis of celiac disease or a gluten sensitivity, or simply because they want to get healthy, many of them have noted a weight loss as part of the benefits they’ve ...

Read More »

Shocking Facts About Celiac Disease

May is National Celiac Disease Awareness Month, so it seems appropriate to share some medical facts about this autoimmune disease that just might shock you. These facts come from Dr. Tom O’Bryan who is is a nationally recognized speaker and workshop leader specializing in gluten sensitivity and celiac disease.  Dr. O’Bryan’s specialty is in teaching the many manifestations of gluten sensitivity and ...

Read More »

Study Finds 1 in 5 Children With Celiac Disease Sustain Intestinal Damage Even on a Gluten-Free Diet

In a new medical study, researchers from MassGeneral Hospital for Children (MGHfC) and Boston Children’s Hospital (BCH) were surprised to discover that nearly one in five children with celiac disease sustained persistent intestinal damage, despite strict adherence to a gluten-free diet.1 These findings are consistent with research in adults, which showed that more than 33 percent of adult patients on ...

Read More »

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

Alba Therapeutics has been working on a therapy for celiac disease the past 8 years. Alba’s therapy, Larazotide Acetate, is the first to reach phase 3 clinical trials, where it will be given to large groups of people. When Alba first contacted us about helping to promote their phase 2 clinical trial, we investigated the therapy’s mechanism and were glad ...

Read More »

Stanford University Seeks Celiac Disease Study Participants

  Jennifer Iscol, of the Celiac Community Foundation of Northern California, just distributed this message regarding a celiac disease study at Stanford University. “Volunteers are needed for a genetic study on celiac disease at Stanford University. Please consider participating. Community participation is an essential component of Stanford’s celiac disease research. The research benefits all of us and future generations. http://www.celiaccommunity.org/stanford-celiac-genetic-study/ Announcement from ...

Read More »

BioLineRX’s BL-7010 Treatment of Celiac Disease and Gluten Sensitivity Presented

BioLineRx Ltd, a biopharmaceutical development company, was invited to deliver an oral presentation at the recent 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease Foundation’s annual conference, in Pasadena, California. Leah Klapper, Ph.D., General Manager, BioLine Innovations Jerusalem, presented BioLineRx’s therapy, BL-7010, for the treatment of celiac, as part of a session entitled Breaking Therapies Beyond the Gluten-Free ...

Read More »

Gluten Free Works Launches Celiac Disease e-Newsletter for Support Group Leaders

December 7, 2012: Port Charlotte, Florida. Gluten Free Works Inc. announced the launch of its newest online publication, Celiac Disease Today. In our ongoing efforts to help people get well and stay healthy, living gluten free, Gluten Free Works is proud to distribute the first issue of Celiac Disease Today, a special new monthly e-newsletter for gluten-free support group leaders.  As the name ...

Read More »